BACKGROUND: The objective of this study was to investigate the performance of a newly developed decision support system for the establishment of tight glycemic control in medical intensive care unit (ICU) patients for a period of 72 hours. METHODS: This was a single-center, open, non-controlled feasibility trial including 10 mechanically ventilated ICU patients. The CS-1 decision support system (interacting infusion pumps with integrated enhanced model predictive control algorithm and user interface) was used to adjust the infusion rate of administered insulin to normalize blood glucose. Efficacy and safety were assessed by calculating the percentage of values within the target range (80-110 mg/dl), hyperglycemic index, mean glucose, and hypoglycemic episodes (<40 mg/dl). RESULTS: The percentage of values in time in target was 47.0% (+/-13.0). The average blood glucose concentration and hyperglycemic index were 109 mg/dl (+/-13) and 10 mg/dl (+/-9), respectively. No hypoglycemic episode (<40 mg/dl) was detected. Eleven times (1.5% of all given advice) the nurses did not follow and, thus, overruled the advice of the CS-1 system. Several technical malfunctions of the device (repetitive error messages and missing data in the data log) due to communication problems between the new hardware components are shortcomings of the present version of the device. As a consequence of these technical failures of system integration, treatment had to be stopped ahead of schedule in three patients. CONCLUSIONS: Despite technical malfunctions, the performance of this prototype CS-1 decision support system was, from a clinical point of view, already effective in maintaining tight glycemic control. Accordingly, and with technical improvement required, the CS-1 system has the capacity to serve as a reliable tool for routine establishment of glycemic control in ICU patients.
BACKGROUND: The objective of this study was to investigate the performance of a newly developed decision support system for the establishment of tight glycemic control in medical intensive care unit (ICU) patients for a period of 72 hours. METHODS: This was a single-center, open, non-controlled feasibility trial including 10 mechanically ventilated ICU patients. The CS-1 decision support system (interacting infusion pumps with integrated enhanced model predictive control algorithm and user interface) was used to adjust the infusion rate of administered insulin to normalize blood glucose. Efficacy and safety were assessed by calculating the percentage of values within the target range (80-110 mg/dl), hyperglycemic index, mean glucose, and hypoglycemic episodes (<40 mg/dl). RESULTS: The percentage of values in time in target was 47.0% (+/-13.0). The average blood glucose concentration and hyperglycemic index were 109 mg/dl (+/-13) and 10 mg/dl (+/-9), respectively. No hypoglycemic episode (<40 mg/dl) was detected. Eleven times (1.5% of all given advice) the nurses did not follow and, thus, overruled the advice of the CS-1 system. Several technical malfunctions of the device (repetitive error messages and missing data in the data log) due to communication problems between the new hardware components are shortcomings of the present version of the device. As a consequence of these technical failures of system integration, treatment had to be stopped ahead of schedule in three patients. CONCLUSIONS: Despite technical malfunctions, the performance of this prototype CS-1 decision support system was, from a clinical point of view, already effective in maintaining tight glycemic control. Accordingly, and with technical improvement required, the CS-1 system has the capacity to serve as a reliable tool for routine establishment of glycemic control in ICU patients.
Entities:
Keywords:
algorithms; critical care nursing; hyperglycemia management; insulin infusion systems
Authors: Greet Van den Berghe; Alexander Wilmer; Ilse Milants; Pieter J Wouters; Bernard Bouckaert; Frans Bruyninckx; Roger Bouillon; Miet Schetz Journal: Diabetes Date: 2006-11 Impact factor: 9.461
Authors: Guillermo E Umpierrez; Scott D Isaacs; Niloofar Bazargan; Xiangdong You; Leonard M Thaler; Abbas E Kitabchi Journal: J Clin Endocrinol Metab Date: 2002-03 Impact factor: 5.958
Authors: Johannes Plank; Jan Blaha; Jeremy Cordingley; Malgorzata E Wilinska; Ludovic J Chassin; Cliff Morgan; Stephen Squire; Martin Haluzik; Jaromir Kremen; Stepan Svacina; Wolfgang Toller; Andreas Plasnik; Martin Ellmerer; Roman Hovorka; Thomas R Pieber Journal: Diabetes Care Date: 2006-02 Impact factor: 19.112
Authors: Stephanie B Clayton; Joseph E Mazur; Stacey Condren; Kathie L Hermayer; Charlie Strange Journal: Crit Care Med Date: 2006-12 Impact factor: 7.598
Authors: Philip A Goldberg; Mark D Siegel; Robert S Sherwin; Joshua I Halickman; Michelle Lee; Valerie A Bailey; Sandy L Lee; James D Dziura; Silvio E Inzucchi Journal: Diabetes Care Date: 2004-02 Impact factor: 19.112
Authors: Sofie Meijering; Anouk M Corstjens; Jaap E Tulleken; John H J M Meertens; Jan G Zijlstra; Jack J M Ligtenberg Journal: Crit Care Date: 2006-02 Impact factor: 9.097
Authors: Franz Feichtner; Julia K Mader; Roland Schaller; Lukas Schaupp; Martin Ellmerer; Stefan Korsatko; Venkata R Kondepati; H Michael Heise; Malgorzata E Wilinska; Roman Hovorka; Thomas R Pieber Journal: J Diabetes Sci Technol Date: 2011-07-01
Authors: Christophe E M De Block; Peter Rogiers; Philippe G Jorens; Tom Schepens; Cosimo Scuffi; Luc F Van Gaal Journal: Ann Intensive Care Date: 2016-11-22 Impact factor: 6.925
Authors: Karin Amrein; Norman Kachel; Heike Fries; Roman Hovorka; Thomas R Pieber; Johannes Plank; Urs Wenger; Barbara Lienhardt; Marco Maggiorini Journal: BMC Endocr Disord Date: 2014-07-29 Impact factor: 2.763
Authors: Kent W Stewart; Christopher G Pretty; Hamish Tomlinson; Felicity L Thomas; József Homlok; Szabó Némedi Noémi; Attila Illyés; Geoffrey M Shaw; Balázs Benyó; J Geoffrey Chase Journal: Ann Intensive Care Date: 2016-03-29 Impact factor: 6.925
Authors: Wilfried Klingert; Jörg Peter; Christian Thiel; Karolin Thiel; Wolfgang Rosenstiel; Kathrin Klingert; Christian Grasshoff; Alfred Königsrainer; Martin Schenk Journal: Intensive Care Med Exp Date: 2018-01-16